T1	Outcomes 141 175	chronic graft-versus-host disease.
T2	Outcomes 788 805	post-transplant).
T3	Outcomes 806 850	Median follow-up time for surviving patients
T4	Outcomes 1034 1129	lower National Institutes of Health Consensus moderate-severe chronic graft-versus-host disease
T5	Outcomes 1153 1193	and late acute graft-versus-host disease
T6	Outcomes 1257 1282	lower prednisone exposure
T7	Outcomes 1287 1324	earlier discontinuation of tacrolimus
T8	Outcomes 1437 1483	in complete immune suppression discontinuation
